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Calcium-activated potassium (KCa) channels are present throughout the central nervous
system as well as many peripheral tissues. Activation of KCa channels contribute to mainte-
nance of the neuronal membrane potential and was shown to underlie the afterhyperpolar-
ization (AHP) that regulates action potential ﬁring and limits the ﬁring frequency of repetitive
action potentials. Different subtypes of KCa channels were anticipated on the basis of their
physiological and pharmacological proﬁles, and cloning revealed two well deﬁned but phylo-
genetic distantly related groups of channels.The group subject of this review includes both
the small conductance KCa2 channels (KCa2.1, KCa2.2, and KCa2.3) and the intermediate-
conductance (KCa3.1) channel.These channels are activated by submicromolar intracellular
Ca2+ concentrations and are voltage independent. Of all KCa channels only the KCa2 chan-
nels can be potently but differentially blocked by the bee-venom apamin. In the past few
years modulation of KCa channel activation revealed new roles for KCa2 channels in con-
trolling dendritic excitability, synaptic functioning, and synaptic plasticity. Furthermore,
KCa2 channels appeared to be involved in neurodegeneration, and learning and memory
processes. In this review, we focus on the role of KCa2 and KCa3 channels in these latter
mechanisms with emphasis on learning and memory, Alzheimer’s disease and on the inter-
play between neuroinﬂammation and different neurotransmitters/neuromodulators, their
signaling components and KCa channel activation.
Keywords: small conductance calcium-activated potassium channels, SK channels, learning and memory,
neurodegeneration
INTRODUCTION
It is widely accepted that the trigger for neurotransmitter release
is the entry of calcium ions (Ca2+) into the presynaptic ter-
minal (Ghosh and Greenberg, 1995). Because of this role of
Ca2+ in neurotransmitter release, many neuronal functions are
dependent on dynamics of Ca2+ signaling. Resting levels of
intracellular free Ca2+ ([Ca2+]i) in neurons are maintained at
very low levels, but can be increased by inﬂux of extracellu-
lar Ca2+ through voltage-, receptor-, or store-operated channels
on the plasma membrane or by release from intracellular Ca2+
stores, predominantly the ryanodine receptor and inositol trispho-
sphate (IP3) receptor dependent endoplasmic reticulum (ER).
Most Ca2+ signals are delivered as brief transients with spatial
and temporal properties. The frequency of the repetitive tran-
sients and the [Ca2+]i obtained encode information to control
cellular processes. Also the localization of these events at speciﬁc
regions of the cell (Ca2+ microdomains), for instance at the plasma
membrane or ER, contribute to the regulation of these cellular
processes (Berridge, 2006). The regulation of these dynamics of
the [Ca2+]i at the Ca2+ microdomain level is critical for proper
neuronal activity, because insufﬁcient levels of [Ca2+] can lead
to impaired functioning whereas excessive cytosolic [Ca2+] lev-
els can cause overstimulation and ultimately cell death (Berridge
et al., 1998).
One way to maintain appropriate intracellular [Ca2+] is repo-
larization of the membrane potential by initiating K+ efﬂux from
the cell. Increased K+ permeability in response to elevated cytoso-
lic [Ca2+] was ﬁrst described in human erythrocytes (Gardos,
1958). Slow hyperpolarizing effects observed after stimulation of
adrenergic, cholinergic, or purinergic pathways in smooth mus-
cles of the gastrointestinal tract were caused by such an increase
in K+ permeability as detected by the use of apamin (Banks
et al., 1979; Maas and Den Hertog, 1979; Shuba and Vladimirova,
1980;DenHertog, 1982). This neurotoxic polypeptidewas isolated
from bee-venom and, when injected in rodents in puriﬁed form,
exerted severe uncoordinated movements of the skeletal muscula-
ture increasing to spasms and convulsions of apparently spinal ori-
gin after a dose-dependent lag time (Habermann, 1984). Apamin
speciﬁcally blocks Ca2+-activated K+ channels and turned out
to be the archetypical blocker for these channels. Such a speciﬁc
blockade was demonstrated for the ﬁrst time in guinea-pig taenia
caeci inwhich changes inmembranepotential andmuscle contrac-
tion were measured using the sucrose-gap method in combination
with 42K+ efﬂux (Den Hertog, 1981) and in differentiating neu-
roblastoma cells using voltage-clamp electrophysiology (Hugues
et al., 1982). Voltage-insensitive Ca2+-activated K+ channels of
the small conductance-type (KCa) were later identiﬁed to carry
these apamin-sensitive currents (Blatz and Magleby, 1986).
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PHARMACOLOGICAL AND MOLECULAR PROPERTIES
Based on their pharmacological and molecular properties a num-
ber of different Ca2+-activated K+ channels can be identiﬁed.
The International Union of Pharmacology has put the Ca2+-
activated K+ channels into one family which can be subdivided
into two functionally deﬁned, but genetically unrelated groups
(Wei et al., 2005). The ﬁrst group consists of four voltage-
insensitive Ca2+-activated K+ channels (Köhler et al., 1996; Ishii
et al., 1997; Joiner, 1997) of which KCa3.1 (formerly called Gardos
channel or intermediate-conductance channel IK1) has a single
channel conductance of 11 pS and is not blocked by apamin.
The other three members of this phylogenetic tree, the KCa
channels KCa2.1, KCa2.2, and KCa2.3, also known as SK1, SK2,
and SK3, with a smaller conductance of 8–10 pS, are speciﬁ-
cally blocked by apamin in the nM range (Wei et al., 2005).
The other group consists of four members of which the large
conductance Ca2+-activated K+channel (KCa1.1, also known as
BK channel) is functionally related to the former group. It is
voltage-dependent with a single channel conductance of 260 pS.
The three other members of this group are structurally related
channel-types which are surprisingly not activated by intracellular
Ca2+.
KCa channels resemble the serpentine transmembrane topology
of voltage-activated K+ channels consisting of six transmembrane
domains and a P loop region between domain S5 and S6, contain-
ing theK+-selectiveﬁlter,and intracellularNandC termini (Faber,
2009). Apamin has different afﬁnities for the KCa2 channel sub-
types. The toxin is most potent at KCa2.2 channels (IC50∼ 70 pM)
followed by KCa2.3 channels (IC50∼ 0.63–6 nM) and the human
isoform of KCa2.1 channels (IC50∼ 1–8 nM; Köhler et al., 1996;
Nolting et al., 2007; Lamy et al., 2010; Weatherall et al., 2010).
Interestingly, the rat isoform of KCa2.1 channel is apamin insensi-
tive (D’Hoedt et al., 2004). Apamin does not simply obstruct the
pore, but blocks by an allosteric mechanism in which outer pore
residues are involved (Lamy et al., 2010). However, apamin must
bind to both the S3–S4 extracellular loop and the outer pore to
block KCa2 channel current by an allosteric mechanism. A three-
amino-acid motif in the S3–S4 loop is a crucial determinant of the
sensitivity of the apamin blockade. Since the motif SYA in KCa2.2
channels, SYT inKCa2.3 channels andTYA in humanKCa2.1 chan-
nels is required for binding and block by apamin, this suggests that
a change in pore shape underlies the allosteric block (Weatherall
et al., 2011). Rat KCa2.1 channels display SLV in the S3–S4 loop
that prevents binding of apamin, despite having the same pore
sequence as the other isoforms (Weatherall et al., 2011). Func-
tional KCa2 channels assemble as homomeric tetramers (Köhler
et al., 1996), but could also co-assemble different subunits into
heteromeric channels (Strassmaier et al., 2005; Weatherall et al.,
2011). Recently, it was proposed that in heteromeric channels the
binding site for apamin is formed by two adjacent subunits, the
outer pore region of one and the S3–S4 loop of the other sub-
unit (Weatherall et al., 2011; Figure 1B). The relative abundance
of heteromeric or homomeric channel assembly and their physi-
ological relevance for signal transduction is not understood at the
moment.
Calmodulin (CaM) is constitutively bound to theC terminus of
the channel (Xia et al., 1998; Schumacher et al., 2001). Binding of
Ca2+ to CaM leads to a conformational change enabling opening
of the channel and K+ efﬂux (Figure 1A). Direct modulation of
the channel can be obtained by phosphorylation, since the protein
has multiple predicted phosphorylation sites (Köhler et al., 1996).
For example, phosphorylation by cAMP-dependent protein kinase
reduces the plasma membrane localization of KCa2 channels and
contributes in this way to long-termpotentiation (LTP; Faber et al.,
2005; Ren et al., 2006; Lin et al., 2008). Modulation of channel
activity can also be achieved by constitutively boundprotein kinase
CK2 (Casein Kinase 2) and protein phosphatase 2A. CK2 phos-
phorylates channel-boundCaM in the closed channel state thereby
reducing the apparent Ca2+ sensitivity. In the open state, dephos-
phorylation of CaM by protein phosphatase 2A increases the Ca2+
sensitivity of the channel (Allen et al., 2007). Therefore, Ca2+ sen-
sitivity is dependent on the intracellular Ca2+ levels enabling KCa
channels to closely follow neuronal activity. Recently, these aspects
of KCa channel signaling have been excellently reviewed (Adelman
et al., 2012).
KCa2 channels interact with a large number of pharmacolog-
ical agents (Faber and Sah, 2007; Pedarzani and Stocker, 2008).
Apart from apamin, other peptides, like leiurotoxin I and tamapin
were found to block the channels at the nanomolar range. Most
of the organic blockers and inhibitors are needed in micromo-
lar concentrations to block the channels, except for UCL1684 and
UCL1848, which also block at the nanomolar range (Shah and
Haylett, 2000; Strobaek et al., 2000; Fanger et al., 2001; Hosseini
et al., 2001; Benton et al., 2003). A different set of toxins is available
to block KCa3.1 channels of which maurotoxin and charybdo-
toxin are the most effective (low nanomolar range). In addition,
triarylmethane derivatives block KCa3.1 channels at the nanomo-
lar range (Ghanshani et al., 2000; Visan et al., 2004). Enhancers
of channel activity are also available. Most of them work at the
micromolar range (Pedarzani and Stocker, 2008), like 1-ethyl-2-
benzimidazolinone (1-EBIO) which acts on KCa2.1, KCa2.2, and
KCa2.3 channels (Lappin et al., 2005) as well as on KCa3.1 channels
(Jensen et al., 1998; Lappin et al., 2005). The only enhancer with
higher afﬁnity is NS309, acting on these channels at the nanomo-
lar range (Strobaek et al., 2004). The positive modulator CyPPA
is selective for KCa2.2 and KCa2.3 channels at the low micromolar
range and virtually inactive toward KCa2.1 and KCa3.1 channels
(Hougaard et al., 2007).
DISTRIBUTION OF KCA CHANNELS IN THE PERIPHERY AND
THE NERVOUS SYSTEM
KCa channels are widely distributed throughout peripheral tissues
and in the central nervous system. In the peripheral tissues mRNA
of the KCa channels has partially overlapping but clearly distinct
distribution patterns. KCa2.1 channels are only found in low quan-
tities in the ovaries and testes. KCa2.2 channels are, next to other
areas, present in the adrenal glands, heart, kidneys, liver, prostate,
and urinary bladder. KCa2.3 shows distinctive distribution to the
small intestine, rectum,omentum,myometrium,and skeletalmus-
cles (Chen et al., 2004). Immunohistochemistry also revealed the
presence of KCa2.3 protein in the cell bodies and processes of
cultured rat superior cervical ganglion neurons and KCa2.3 pro-
tein was identiﬁed as a major component of the KCa channels
responsible for the afterhyperpolarization (AHP) in these cells
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FIGURE 1 | Plasticity in the glutamatergic synapse and the role of KCa
channels. (A) (1) During synaptic transmission, glutamate is released from
the presynaptic neuron and acts on the two primary excitatory glutamate
receptors: AMPA (α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate)
receptors and NMDA (N -Methyl-d-Aspartate) receptors. (2) Na+ ﬂows only
through AMPARs and not through NMDARs because the NMDAR is
blocked by a voltage-dependent Mg2+ block. (3) Inﬂux of Na+ causes
depolarization of the postsynaptic neuron. (4) The depolarization relieves
the Mg2+ block of the NMDAR and an excitatory postsynaptic potential
(EPSP) is induced. (5) This allows, next to Na+, for Ca2+ inﬂux into the
dendritic spine. Changes in the dendritic spine Ca2+ concentration can
initiate synaptic plasticity. The dynamics of changes in [Ca2+] upon tetanic
stimulation determines whether the synapse will undergo long-term
potentiation (LTP) or long-term depression (LTD). (6) Ca2+ can also be
released from the ER, predominantly dependent on ryanodine receptors
and inositol trisphosphate receptors (IP3R). (7) When intracellular levels of
Ca2+ increase, KCa channels are activated through calmodulin (CaM). Ca2+
binds to CaM and CaM induces a conformational change that leads to
opening of the channel pore. (8) Opening of the KCa channel leads to K+
efﬂux. KCa channels also facilitate reestablishment of the Mg2+ block of the
NMDARs which reduces Ca2+ inﬂux. In this way opening of KCa channels
provides a negative feedback on the EPSP through their repolarizing effect.
(9) Binding of apamin to the KCa channel blocks the channel and induces an
increased EPSP. (B) Apamin does not obstruct the pore of the KCa channel
but blocks it by an allosteric mechanism. The binding site for apamin is
formed by two adjacent subunits, the S3–S4 extracellular loop of one and
the loops of the outer pore of the other, also providing a block on
heteromeric channels.
(Hosseini et al., 2001). KCa3.1 channels are abundantly distributed
in peripheral tissues like lymphocytes (Ghanshani et al., 2000),
erythrocytes (Vandorpe et al., 1998), endothelium (Eichler et al.,
2003), and smooth muscle cells (Köhler et al., 2003), but they
are also present on the placenta, prostate, rectum, salivary glands,
trachea, and tonsils (Chen et al., 2004). The different channels
have been implicated in various physiological functions like vol-
ume regulation of erythrocytes (Brugnara et al., 1996; Vandorpe
et al., 1998), vasodilatation (Eichler et al., 2003), and prolifera-
tion of lymphocytes (Jensen et al., 1999), proliferation of vascular
endothelial (Grgic et al., 2005), andproliferation of smoothmuscle
cells (Köhler et al., 2003).
Different subunits of the KCa channels are widely distributed
throughout the brain (Figure 2). KCa2.1 and KCa2.2 channels
are often expressed in the same neurons, predominantly in the
neocortex, hippocampal formation, and cerebellum. In the hip-
pocampal formation KCa2.1 channel immunolabeling is most
pronounced in the neuropil of layers CA1–CA3, in particular in
the stratum radiatum. KCa2.2 channel labeling is strongest in the
CA1–CA2 stratum radiatumand stratumoriens (Sailer et al., 2002,
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FIGURE 2 | Distribution of (A) KCa2.1, (B) KCa2.2, and (C) KCa2.3 proteins in
various compartments of the mouse central nervous system. CTX,
neocortex. HPF, hippocampal formation CA1–CA3 region; so, stratum oriens; sp,
stratum pyramidale; sr, stratum radiatum; slm, stratum lacunosum moleculare;
slu, stratum lucidum. Dentate gyrus; mo, molecular layer; sg, granule cell layer.
HY, hypothalamus; LHA, lateral hypothalamic area; ARH, arcuate hypothalamic
nucleus; ME, median eminence. BLAa, basolateral amygdalar nucleus, anterior
part; BLAp, basolateral amygdalar nucleus, posterior part; BLAv, basolateral
amygdalar nucleus, ventral part; BMAp, basomedial amygdalar nucleus,
posterior part based on data from Sailer et al. (2004).
2004). KCa2.3 subunits are also present in the hippocampal for-
mation, most prominent in the hilus and in the stratum lucidum
of CA3. In the rest of the brain KCa2.3 subunits show a com-
plementary distribution to KCa2.1 and KCa2.2 subunits. KCa2.3
subunits are present in subcortical regions like midbrain nuclei
(Rimini et al., 2000; Stocker and Pedarzani, 2000; Tacconi et al.,
2001; Sailer et al., 2002, 2004; Chen et al., 2004). In dorsal root
ganglia and spinal cord of the rat sensory nervous system, all
KCa2 channel subtypes are expressed. Co-localization of chan-
nel expression with calcitonin gene-related peptide and isolectin
B4-labeled neurons provides evidence for their presence in noci-
ceptors (Mongan et al., 2005). Their level of expression, however,
was not altered following induction of inﬂammation or nerve
injury, suggesting that channel modulation rather than expres-
sion contributes to the changes in neuronal excitability observed
under these “pathological” circumstances (Mongan et al., 2005).
Within neurons, KCa2.1 and KCa2.2 channels are primarily
found in somatic and dendritic areas. KCa2.2 channels have been
shown to be present in hippocampal CA1 dendritic spines (Lin
et al., 2008). KCa2.3 channels are associated with ﬁbers extend-
ing from layer 5 to layer 1 in the neocortex (Rimini et al., 2000;
Stocker and Pedarzani, 2000; Tacconi et al., 2001; Sailer et al.,
2002, 2004; Chen et al., 2004). KCa3.1 channels are present in
dorsal root ganglia, spinal cord and on cultured microglial cells
from rat and mouse brain (Khanna et al., 2001; Schilling et al.,
2002; Mongan et al., 2005; Kaushal et al., 2007). In microglial
cells, KCa3.1 channels are activated by sphingosine-1-phosphate
and lysophosphatidic acid and play a role in the respiratory bursts
of reactive oxygen species generated after activation of microglia
(Khanna et al., 2001; Schilling et al., 2002). The properties of the
different channels have been reviewed in detail (Pedarzani and
Stocker, 2008), and in particular as possible targets for therapeutic
interventions because in the past few years the role of KCa chan-
nels in disease is becoming more and more clear (Chandy et al.,
2004; Wulff and Zhorov, 2008). The distribution of the different
KCa channels gives the channels the ability to play a role in many
processes like dendritic excitability, contributing to the AHP that
follows an action potential, synaptic functioning, and plasticity
(Xia et al., 1998; Ngo-Anh et al., 2005) and thereby modulating
ﬁring patterns of action potentials, all processes known for their
involvement in learning and memory and in neurodegenerative
diseases. The main focus of this review is the role of KCa chan-
nels in neurodegenerative processes, and in learning and memory.
However, to place KCa channel research in a historical perspective
ﬁrst two important peripheral pathways which are under control
of KCa channels will be discussed.
GASTROINTESTINAL TRACT
KCa channels are important participants in inhibitory neuro-
transmission in gastrointestinal smooth muscles (Banks et al.,
1979; Maas et al., 1980; Shuba and Vladimirova, 1980). Three
isoforms of the KCa2 channel family were cloned from murine
and canine proximal colon smooth muscle (Ro et al., 2001).
The mRNA of each subunit was expressed at different levels
in murine colonic smooth muscles in the following sequence:
KCa2.2>KCa2.3>KCa2.1 channels. In contrast, no mRNA for
these channels could be detected in canine colonic smooth mus-
cle. Immunoreactivity against KCa2.3 channels was present at the
plasma membrane of circular and longitudinal muscle as well
as in myenteric ganglia. Variation in the KCa2 channel expres-
sion suggests that they may contribute differentially to inhibitory
junction potentials (Ro et al., 2001). A role for KCa2 channels
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in spontaneous motility of the gastrointestinal tract has been
suggested. KCa2.3-immunoreactive cells were positive for c-kit, a
marker for the interstitial cells of Cajal (ICC), but not for glial ﬁb-
rillary acidic protein in the ileum and stomach. Immunoelectron
microscopic analysis indicates that KCa2.3 channels are localized
on processes of ICC that are located close to the myenteric plexus
between the longitudinal and circular muscle layers and within the
muscular layers. Because ICC have been identiﬁed as pacemaker
cells and are known to play a major role in generating the regular
motility of the gastrointestinal tract, these ﬁndings suggest that
KCa2.3 channels, which are expressed speciﬁcally in ICC, play an
important role in generating a rhythmic pacemaker current in the
gastrointestinal tract (Fujita et al., 2001).
VASCULAR RELAXATION
The endothelium-derived hyperpolarizing factor (EDHF) system
is a major vasodilator mechanism (Taylor and Weston, 1988; Félé-
tou andVanhoutte, 2007, 2009; Edwards et al., 2010). The function
of the EDHF system requires activation of endothelial KCa chan-
nels (Edwards et al., 2010), e.g., KCa3.1 channels (Ishii et al., 1997)
and KCa2.3 channels (Köhler et al., 1996). Contribution of KCa
channels has been implicated in endothelial dysfunction in many
experimental models of vascular disease (Félétou and Vanhoutte,
2009), among which are coronary microvascular dysfunction
(Gschwend et al., 2003; Feng et al., 2008), hypercholesterolemia
(Ding et al., 2005; Morikawa et al., 2005), and diabetes (Dalsgaard
et al., 2009; Brøndum et al., 2010;Matsumoto et al., 2010). A possi-
ble role for these channels in antihypertensive therapy is emerging
(Sankaranarayanan et al., 2009). Newly developed activators were
shown to potentiate EDHF-mediated dilations of carotid arteries
from KCa3.1(+/+) mice but not from KCa3.1(−/−) mice. Admin-
istration of these activators lowered mean arterial blood pressure
by 4 and 6mmHg in normotensive mice and by 12mmHg in
angiotensin-II-induced hypertension. These effects were absent in
KCa3.1-deﬁcient mice. In addition, changes in arterial blood ﬂow
for 24 h modify the function of the endothelial KCa2.3 and KCa3.1
channels before arterial structural remodeling in rat mesenteric
arteries. Reduction of blood ﬂow blunts endothelium-dependent
relaxation due to a reduction in the EDHF response. An increase
in blood ﬂow leads to an enhanced contribution of KCa3.1 chan-
nels to the EDHF relaxation, as indicated by the use of speciﬁc
blockers (Hilgers et al., 2010). An endothelium-speciﬁc antihy-
pertensive therapy based on pharmacological activation of these
channels is also supported by recent experiments in dogs showing
that activation of KCa2.3/KCa3.1 channels produces endothelial
hyperpolarization and lowers arterial blood pressure by an imme-
diate electrical vasodilator mechanism (Damkjaer et al., 2012).
Apart from their role in cardiovasculature, KCa3.1, KCa2.2, and
KCa2.3 channels are also functional in endothelium-dependent
vasodilatation in porcine retinal arterioles (Dalsgaard et al., 2010),
and very important in the regulation of contraction mechanisms
of brain (micro)vasculature to maintain homeostasis of the brain
(Zhou et al., 2010).
STROKE
KCa2 and KCa3.1 channels are expressed in cerebral blood ves-
sels and play a signiﬁcant role in the regulation of local blood
ﬂow (Marrelli et al., 2003; Faraci et al., 2004; McNeish et al.,
2005). The release of K+ through the channels accumulates in the
myo-endothelial space between the endothelial cells and myocytes
of small arteries, causing an increase in the extracellular K+
concentration (Edwards et al., 2010). This increased extracellu-
lar K+ results in hyperpolarization of the myocyte and leads to
smooth muscle relaxation and vascular dilation (Weston et al.,
2002; Longden et al., 2011). Activity of KCa2 and KCa3.1 chan-
nels can play an important role in vascular dynamics under
pathophysiological conditions, like cerebral ischemia. An EDHF-
mediated relaxation mechanism is present in the carotid artery –
together with the vertebral arteries the main feed path for blood
supply to the brain – as well as in cerebral parenchymal arte-
rioles (McNeish et al., 2006; Leuranguer et al., 2008; Cipolla
et al., 2009; Sankaranarayanan et al., 2009). The EDHF compo-
nent can activate KCa2 and KCa3.1 channel activity, regulating
cerebral blood ﬂow and contributing to the basal tone of cere-
bral parenchymal arterioles. Activators of KCa3.1 channel activity
were shown to potentiate EDHF-mediated dilations of rat mid-
dle cerebral arteries (Marrelli et al., 2003), the carotid arteries in
mouse (Sankaranarayanan et al., 2009) and in guinea-pig which
is mediated by stimulation of both KCa2 and KCa3.1 channels
(Leuranguer et al., 2008). Endothelial KCa2 and KCa3 channels
regulate rat brain parenchymal arteriolar diameter and basal
tone (Cipolla et al., 2009; Hannah et al., 2011) and via these
endothelial mechanisms can determine cortical cerebral blood
ﬂow as was demonstrated in mice (Hannah et al., 2011). After
cerebral ischemia and subsequent reperfusion, EDHF respon-
siveness was preserved in rat parenchymal arterioles, in contrast
to the diminished response to nitric oxide synthase inhibition,
providing further support for an important physiological role
for KCa2 and KCa3.1 channels under pathophysiological condi-
tions (Cipolla et al., 2009). KCa channels do not only play a
role in regulating blood ﬂow to different brain regions, but also
in maintenance of the structure of the blood-brain barrier as
the activation of KCa2.2 channels is necessary for ATP-induced
proliferation of brain capillary endothelial cells (Yamazaki et al.,
2006).
In addition to effects on the (micro)vasculature, KCa channels
are also involved in the pathogenic mechanisms subsequent to
the ischemic event. Cerebral ischemia induced in mice by cardiac
arrest and cardiopulmonary resuscitation caused hippocampal
CA1 pyramidal neuronal cell death associated with delayed and
sustained reduction of synaptic KCa2.2 channel activity (Allen
et al., 2011b). Treatment of mice with the KCa channel activator 1-
EBIO 30min before cardiac arrest prevented ischemia-induced
synaptic channel internalization, restored channel activity, and
reduced ischemia-induced cell death (Allen et al., 2011b). The
brain infarct area obtained after occlusion of the middle cere-
bral artery of the rat could be reduced by ±50% by blocking
KCa3.1 channels, probably reﬂecting reduced microglia activity
(Chen et al., 2011). During stroke there is strong increase of
glutamate release and overstimulation of nerve cells, which goes
together with very high calcium levels in neurons and their death.
The role of KCa2 and KCa3.1 channels in NMDA-mediated neu-
rotoxicity will be addressed in the section “Neurodegenerative
diseases.”
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LEARNING AND MEMORY
Learning is by deﬁnition the result of processes by which experi-
ences produce long-term and lasting changes in the nervous sys-
tem. Memory formation is derived from those changes (Morgado-
Bernal, 2011). Memory formation and persistent memory storage
are accompanied by structural changes and synaptic plasticity of
dendritic spines. Due to repetitive activation of excitatory gluta-
matergic synapses, particularly in CA1 pyramidal neurons of the
hippocampus, an increase in synaptic strength is established, also
known as LTP (Bliss and Collingridge, 1993). LTP is a form of
plasticity that has been studied extensively in the hippocampus
region of the brain. Plasticity is facilitated by phosphorylation
of AMPA receptors and NMDA receptors. These receptors are
the two primary excitatory glutamate receptors which can be
found at the postsynaptic site of excitatory synapses. NMDARs
particularly can be found on almost all neurons in the central
nervous system and are ligand-gated non-selective cation chan-
nels which facilitate the ﬂow of K+, Na+, and Ca2+ (Debanne
et al., 2004; Yamin, 2009; Malenka and Malinow, 2011). In hip-
pocampal CA1 pyramidal neurons, changes in dendritic spine
Ca2+ concentration can initiate synaptic plasticity via the NMDA
receptors (El-Hassar et al., 2011; O’Donnell et al., 2011). KCa2
channels are able to dampen synaptic plasticity, because KCa2
channels have been shown to be present in the hippocampal CA1
synaptic membrane of dendritic spines in the postsynaptic den-
sity (PSD), where they are colocalized with NMDA receptors (Lin
et al., 2008; Allen et al., 2011b). During an excitatory postsynap-
tic potential (EPSP), Ca2+ enters a neuron through NMDARs and
nearby KCa2 channels are activated. Opening of KCa2 channels has
a repolarizing effect and the EPSP is reduced, ﬁrstly by providing
K+ efﬂux and secondly through modulation of the membrane
potential. Opening of KCa2 channels can facilitate reestablish-
ment of the Mg2+ block of the NMDARs which reduces Ca2+
inﬂux (Allen et al., 2011b). By regulating Ca2+ concentrations,
KCa2 channels can alter the threshold for the induction of hip-
pocampal synaptic plasticity and modulate EPSPs underlying the
induction of LTP (Hammond et al., 2006; Lin et al., 2008). In
concordance with these results it has been shown that during LTP
induction in mouse hippocampus, KCa2 channels are internal-
ized into the dendritic spine due to PKA phosphorylation of three
serine residues in the KCa2.2 C-terminal domain. Internalization
of KCa2 channels abolishes KCa2 channel activity in the potenti-
ated synapses and this results in increased EPSP (Lin et al., 2008;
Figure 1).
Since KCa2 channels reduce synaptic plasticity, it can be
expected that inhibition of KCa2 channels improves learning.
Indeed, the excitability of rat hippocampal neurons can be
enhanced by blocking KCa2 channels with apamin within a
nanomolar concentration range (Behnisch and Reymann, 1998).
In mice, hippocampal learning and induction of synaptic plas-
ticity can be increased with apamin treatment (Stackman et al.,
2002). Blocking KCa2 channels can remove the negative feedback
on NMDARs, while LTP induction can be facilitated by NMDAR-
dependent Ca2+ signals within dendritic spines in the hippocam-
pal CA1 area (Stackman et al., 2002; Faber et al., 2005; Ngo-Anh
et al., 2005; Allen et al., 2011a). The KCa channel subtype KCa2.2
especially appears to be involved in regulating CA1 plasticity and
excitability, because genetic deletion of KCa2.2 channels, but not
KCa2.1 orKCa2.3,abolishes the effect of apamin (Bond et al., 2004).
TheKCa2.2 channel has two isoforms,KCa2.2-long (KCa2.2-L) and
KCa2.2-short (KCa2.2-S),which are coexpressed in CA1 pyramidal
neurons. In mice lacking KCa2.2-L isoform, KCa2.2-S-containing
channels are expressed in the extrasynaptic spine plasma mem-
brane but they are speciﬁcally excluded from the PSD of dendritic
spines. Due to this exclusion, apamin does not increase EPSPs
or LTP in these mice. It is suggested that the KCa2.2-L isoform
directs synaptic KCa2.2 channel expression and is important for
normal synaptic signaling, plasticity, and learning (Allen et al.,
2011a).
Many studies on the role of KCa2 channels in learning and
memory consolidation have been performed using various kinds
of behavioral tasks and paradigms in rodents. Hippocampal-
dependent learning and memory can be tested using spatial
learning tasks, like radial arm mazes, Y- or T-mazes and water
mazes, avoidance test, fear conditioning, eyeblink conditioning,
or using novel object-recognition tasks (Geinisman et al., 2001;
Borght van der et al., 2005; Havekes et al., 2006; Morgado-
Bernal, 2011). It was shown that in the early stages of a spatial
learning task KCa2.2 and KCa2.3 mRNA levels were transiently
downregulated, suggesting an endogenous regulation of KCa2
channels involved in learning (Mpari et al., 2010). In the hip-
pocampus of aged mice an elevated expression of KCa2.3 chan-
nels contributes to an age-related reduction in performance on
learning tasks, synaptic plasticity, and LTP (Blank et al., 2003).
However, mice lacking KCa2.3 channels show short-term learn-
ing and memory deﬁcits in their performance in an alterna-
tion arm maze test (Jacobsen et al., 2009). Mice treated with
apamin also demonstrate accelerated hippocampal-dependent
spatial and non-spatial memory encoding. Apamin-treated mice
require fewer trials to learn the location of a hidden platform
in the Morris water maze. In mice, and also rats, apamin facil-
itates the encoding of object memory in an object-recognition
task, as assessed by habituation of exploratory activity. Moreover,
apamin improves performance on the novel object-recognition
task (Deschaux et al., 1997; Stackman et al., 2002). Amygdala-
dependent learning or emotional learning is tested with inhibitory
avoidance tests, contextual fear memory tests, and with the appet-
itive motivated response. Blockade of KCa2 channels with sys-
temically administered apamin was shown to facilitate mem-
ory processes in conditioning for an appetitively motivated bar-
pressing response in mice (Messier et al., 1991). Interestingly,
apamin did not alter performance in rats when administered at
different time points in a passive avoidance test, which might
indicate that acquisition, consolidation and retention are not
enhanced by apamin (Deschaux and Bizot, 1997). In a discrim-
ination avoidance task in young chicks, blocking KCa2 channels
with apamin resulted even in persistent impairment of retention
during the long-term memory stage, which might indicate that
KCa2 channels play a role in long-term memory (Baker et al.,
2011). Taken together, these studies indicate that blocking KCa2
channels results in an LTP increase and in learning improve-
ment. In hippocampus-dependent tasks, the effect of blocking
KCa2 channels is more evident than in amygdala-dependent
tasks.
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Blocking of KCa2 channel activity by apamin can also be of
interest in alcohol and drug addiction which is associated with
long-lasting changes in the activity of neuronal networks. Molecu-
lar changes in K+ channel function are linked to an enhancement
of drug-seeking behavior. In ex vivo rat neurons from the core
nucleus accumbens (NAcb), a reduction in KCa channel currents
can signiﬁcantly enhance spike ﬁring after abstinence from alco-
hol, but not after sucrose abstinence, and facilitates motivation to
seek alcohol following protracted abstinence. Inhibition of KCa
channels with apamin produces a greater enhancement of ﬁr-
ing in neurons from sucrose- versus alcohol-abstinent animals,
indeed indicating reduced KCa currents. Activation of KCa chan-
nels in NAcb core neurons with the positive modulator 1-EBIO
signiﬁcantly inhibits ﬁring of neurons ex vivo and reduces alco-
hol seeking after abstinence in vivo. Apamin can fully reverse the
effect of 1-EBIO ex vivo, indicating that 1-EBIO depressed ﬁring
through KCa channel activation. Also the positive KCa channel
modulator chlorzoxazone can inhibit ﬁring in NAcb core neurons
ex vivo and signiﬁcantly and dose-dependently decrease alcohol
intake in rats with intermittent access to alcohol compared to rats
with continuous access to alcohol (Hopf et al., 2010, 2011a,b).
Chronic exposure to alcohol in vitro and in vivo also reduces hip-
pocampal CA1 pyramidal neuronal KCa2 channel function and
reduces KCa2 expression with concomitant increases in NMDAR
speciﬁcally at synaptic sites. Apamin potentiated EPSPs in con-
trol but not in ethanol-treated neurons, suggesting disruption of
the KCa2-NMDAR feedback loop. Increasing channel activity by
1-EBIO decreased alcohol withdrawal hyperexcitability and atten-
uated ethanol withdrawal neurotoxicity in hippocampus (Mul-
holland et al., 2011). Endocannabinoid signaling is potentiated by
KCa2 channels resulting in an enhanced AHP current and spike-
frequency adaptation, shown by examining the endocannabinoid
anandamide in cultured rat hippocampal neurons (Wang et al.,
2011). Mice with cannabinoid tolerance, such as observed in drug
addiction, show impaired endocannabinoid-induced long-term
depression (LTD) and the reversal of LTP in the dorsolateral stria-
tum. In vivo modulation of KCa2 channel activity by apamin can
potentiate the endocannabinoid signaling and rescue the deﬁcit
in LTD and corresponding behavioral alterations. Striking also
is the observation that the KCa channel stimulator NS309 has the
reversed effect (Nazzaro et al., 2012). Stimulation of KCa2 channels
results in a reduction of LTP and learning in both hippocampus-
and amygdala-dependent tasks (Hammond et al., 2006). 1-EBIO
facilitates KCa2 channel activation by increasing their sensitivity
to Ca2+. Systemic administration of 1-EBIO results in impaired
motor and cognitive behavior in mice and facilitates object mem-
ory encoding but not retrieval. The compound CyPPA, which can
selectively activate KCa2.2 andKCa2.3 channels, has the same effect
as 1-EBIO (Vick et al., 2010). Next to activation, overexpression
of KCa2.2 channels results in deﬁcits in hippocampal contextual
memory encoding and synaptic plasticity.However,KCa2 channels
constrain, but do not fully prevent hippocampal synaptic plasticity
(Stackman et al., 2008).
NEURODEGENERATIVE DISEASES
With increasing age, memory impairments, and neurodegener-
ative diseases like Alzheimer’s disease occur more frequent and
substantial changes in neuronal signal processing in the hip-
pocampus are observed. Alterations in Ca2+ signaling might
be one of the underlying cause of changes in signal process-
ing (Norris et al., 1998; LaFerla, 2002; Stutzmann, 2005). It was
hypothesized that during aging Ca2+ levels may slowly increase,
affecting critical Ca2+ signaling throughout cells and affecting cel-
lular activity (Toescu et al., 2004; Shetty et al., 2011). Indeed,
in neurons from aged rats, elevated levels of [Ca2+]i can lead
to a prolonged Ca2+-dependent K+-mediated AHP, resulting
in deleterious effects on neurons (Landﬁeld and Pitler, 1984;
Norris et al., 1998). Also an immediate abnormal increase in
[Ca2+]i and exacerbated activation of glutamate receptor-coupled
Ca2+ channels, like NMDA receptors, are established hallmarks
of neuronal cell death in acute and chronic neurological dis-
eases (Dolga et al., 2011). Neurons modulate Ca2+ signals by
regulating the inﬂux into the cell from the extracellular envi-
ronment or by its release from internal sources such as the
ER via IP3 receptors and ryanodine receptors in the ER mem-
brane (LaFerla, 2002; Stutzmann, 2005). The regulation of the
[Ca2+]i is critical, because insufﬁcient levels of [Ca2+] can lead
to impaired functioning whereas excessive cytosolic [Ca2+] levels
can cause overstimulation and even cell death (Berridge et al.,
1998). Several factors can trigger increases in [Ca2+]i in neu-
rons, like exposure to glutamate, which activates NMDA recep-
tors (Randall and Thayer, 1992; Dolga et al., 2011). In physi-
ological conditions, glutamate receptor-coupled Ca2+ channels
are responsible for the primary depolarization in glutamate-
mediated neurotransmission and changes in dendritic spine Ca2+
concentration play a key role in initiating synaptic plasticity
(Santos et al., 2009; El-Hassar et al., 2011; O’Donnell et al.,
2011).
Next to changes in [Ca2+], functional alterations in KCa chan-
nels can play a signiﬁcant role in the regulation of Ca2+ home-
ostasis in aging and neurodegenerative diseases (LaFerla, 2002).
In the hippocampus of aged mice an elevated expression of
KCa2.3 channels contributes to an age-related reduction in perfor-
mance on learning tasks, synaptic plasticity and LTP (Blank et al.,
2003). In patients with multiple sclerosis (MS), KCa2 channels
may signiﬁcantly contribute to neuroprotection. In MS glutamate
receptors are involved in glial activation and pathological changes
in axonal processes associated with progressive brain damage.
Improvements of symptoms are seen with treatment with rilu-
zole, a neuroprotective agent that inhibits the release of glutamate
from nerve terminals, reduces neuronal excitability and acti-
vates KCa2 channel activity, indicating a protective role of KCa2
channels (Cao et al., 2002; Geurts et al., 2003; Killestein et al.,
2005). Neuroprotection can also be promoted by pharmacologi-
cal positive modulation of KCa2.2 channels by NS309 in vitro by
reducing glutamate- and NMDA-induced delayed Ca2+ deregu-
lation (DCD), which is responsible for apoptotic neuronal death
(Figure 3). Glutamate-induced DCD is paralleled by downregu-
lation of KCa2.2 channel expression in a time-dependent man-
ner in primary cortical neurons, which may explain the lack
of adaptation to extended glutamate receptor stimulation, and
the NS309 therapeutic time window. As shown by Dolga et al.
(2011), NS309 mediated neuroprotection only when applied up
to 3 h after the onset of [Ca2+]i deregulation, an effect that
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FIGURE 3 | Effect of a negative modulator (NS8593) and an positive
modulator (NS309) of KCa channel activity on the glutamate
(Glu)-induced intracellular Ca2+ concentrations of primary cortical
neurons, seen as changes in fluorescence intensities of the
Ca2+-sensitive dye FURA-2. Single neurons were stimulated with
glutamate (20μM) and then treated with NS309 (50μM), NS8593 (50μM;
obtained with permission from Dolga et al., 2011).
correlates with the time window of the progressive decline of
KCa2.2 channel expression levels upon glutamate damage. These
data were substantiated in in vivo stroke studies of middle cere-
bral artery occlusion and focal ischemia, which cause signiﬁcant
cell loss and reduced KCa2.2 channel activity due to the inter-
nalization of synaptic KCa2.2 channels (Allen et al., 2011b). In
both studies, pharmacological activation of KCa2 channels with
either NS309 or 1-EBIO reduced neuronal death and ischemic
braindamage,and restoredKCa2.2 channel expression andactivity.
Thus, the activation of KCa2.2 channels could be used as poten-
tial therapeutic strategy for the treatment of acute and chronic
neurodegenerative disorders (Allen et al., 2011b; Dolga et al.,
2011).
ALZHEIMER’S DISEASE
In Alzheimer’s disease (AD) certain parts of the brain like the hip-
pocampus are especially vulnerable to pathogenic mechanisms.
Early degenerative symptoms include signiﬁcant deﬁcits in the
performance of hippocampal-dependent cognitive abilities such
as spatial learning and memory (Yamin, 2009). AD has many
hallmarks including neuroinﬂammation and accumulation of β-
amyloid (Aβ) plaques and tau pathology (Maezawa et al., 2011).
Recent experimental evidence suggests that Aβ oligomers disturb
the NMDA receptor-dependent LTP induction in the hippocam-
pal CA1 and DG regions both in vivo and in vitro (Stutzmann,
2005; Yamin, 2009). The disturbance by Aβ and inﬂammation can
lead to a destabilization of Ca2+ signaling, which seems to be
central to the pathogenesis of AD (LaFerla, 2002; Santos et al.,
2009). However, some forms of Ca2+ dysregulation may repre-
sent compensatory mechanisms to modulate neuronal excitability
and slow AD pathology in the early stages of the disease (Supnet
and Bezprozvanny, 2010). KCa2 channels can provide a negative
feedback on Ca2+ signaling through interaction with NMDA
receptors, reducing lethal amounts of Ca2+ inﬂux (Allen et al.,
2011b).
Recently, KCa3.1 channels have been found to play a role
in AD. KCa3.1 channels are present in microglia, which are
activated by aggregated forms of Aβ. Aβ oligomers induce a
unique pattern of microglia activation that requires the activity
of KCa3.1 channels (Maezawa et al., 2011). Suppression of KCa3.1
might be useful for reducing microglia activity in stroke, trau-
matic brain injury, MS, and Alzheimer’s disease (Chen et al.,
2011). In brain tissue, cerebrospinal ﬂuid and plasma in AD
and in other central nervous system disorders, the inﬂamma-
tory cytokine tumor necrosis factor-α (TNF-α) is found to be
increased. An increase in TNF-α increases the expression of
KCa2.2 channels in cortical neurons (Murthy et al., 2008). TNF-
α has been implicated as contributing to both neuroprotection
and neurodegeneration, depending on the tissue and experimen-
tal paradigm and the increase in KCa2 channels makes neu-
rons more resistant to excitotoxic cell death. In an in vitro
model of glutamate-induced cell death of primary cortical neu-
rons, TNF-α was shown to have neuroprotective properties. By
blocking KCa2 channels with apamin, the neuroprotective effect
of TNF-α against glutamate-induced excitotoxicity was blocked
(Dolga et al., 2008). In addition to this results, in cortical tis-
sue from AD patients a signiﬁcantly higher expression level of
a short, inactive form of KCa2.2 mRNA has been found which
impairs the negative feedback of KCa2.2 channels on Ca2+ sig-
naling and probably also had a negative effect on the neuro-
protective effect of TNF-α (Murthy et al., 2008). Also in mice
with KCa2.2-S-containing channels, the channels were excluded
from the PSD and EPSPs or LTP were not increased by adding
apamin (Allen et al., 2011a). In contrast to this result, in mice
with partial hippocampal-lesions, mimicking the pathophysio-
logical hallmark also observed in AD, blocking KCa2 channels
by apamin could alleviate the impairment in spatial reference
memory and working memory (Ikonen and Riekkinen, 1999).
Due to these ﬁndings, apamin has been proposed as a ther-
apeutic agent in AD treatment (Romero-Curiel et al., 2011).
It is of interest to determine whether KCa2.2 channel protein
expression increases with age and whether blocking KCa2.2 chan-
nels can limit age-related memory impairment (Stackman et al.,
2008).
CONCLUSION
Three decades of research on KCa channels has revealed a broad
range of processes in which these channels are critically involved.
The apamin-sensitive KCa2 channels contribute to the AHP and
are crucial regulators of neuronal excitability. Several compounds
affecting these channels have been synthesized and tested in mod-
els for neurological diseases in vitro as well as in vivo. Some of
these features are summarized in Table 1. In the nearer future,
treatment of neurodegenerative diseases caused by neuronal
hyperexcitability, progressive disturbance of Ca2+ homeostasis
and excitotoxic neuronal death might beneﬁt from enhancers of
KCa2 channel activity, whereas, although less clear, deﬁciencies
in learning and memory might beneﬁt from inhibition of these
channels.
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